CVR 41193093Private limited company (ApS)Engroshandel med medicinalvarer og sygeplejeartikler (464610)København KFounded 24 Feb 2020
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Organon Denmark ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
7
CVR registry, Aug 2026
-4 (-36.4%) over 12 months
Revenue
61.6M
DKK, annual report 2025
-17% on 2024
Result
+3.1M
DKK, annual report 2025
Equity
31M
DKK, annual report 2025
OBS Human Health Holding B.V.100% of capital and votes, since 3 Nov 2020
Karl Johan Sundtsince 13 Jun 2025
Anne Bitzersince 24 Jul 2025
Sofia Raquel Paulos Ferreira Alves da Silvasince 24 Jul 2025
100% of capital and votessince 3 Nov 2020
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
100% of capital and votes24 Feb 2020 to 3 Nov 2020
CVR records founders at incorporation. It does not record whether they are alive or still involved.
13 Jun 2025 to 6 Nov 2026.
24 Feb 2020 to 6 Nov 2026.
Aug 2026, monthly: 7 employees, 5 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 4 | 5 | 6 | 13 | 14 | 14 | 13 | 13 | 13 | 13 | 12 | 13 | 12 | 12 | 12 | 12 | 14 | 13 | 14 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 15 | 16 | 15 | 15 | 15 | 15 | 14 | 14 | 15 | 14 | 14 | 16 | 15 | 15 | 15 | 15 | 15 | 15 | 14 | 14 | 13 | 13 | 13 | 18 | 15 | 12 | 11 | 11 | 11 | 11 | 10 | 9 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 7 |
| FTE | 4 | 5 | 5 | 12 | 13 | 13 | 13 | 12 | 11 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 14 | 13 | 14 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 15 | 15 | 15 | 15 | 15 | 14 | 14 | 14 | 14 | 14 | 13 | 16 | 15 | 15 | 15 | 15 | 15 | 15 | 14 | 13 | 13 | 13 | 13 | 16 | 13 | 12 | 11 | 11 | 11 | 11 | 10 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 5 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Nov 2020 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 50,982 | 61,971 | 63,900 | 74,127 | 61,554 |
| Gross profit | Not reported | Not reported | Not reported | Not reported | 18,570 |
| Operating profit | +1,255 | +2,858 | +3,406 | +2,785 | +3,871 |
| Result for the year | +857 | +2,139 | +2,924 | +2,428 | +3,139 |
| Equity | 24,420 | 26,558 | 29,482 | 27,910 | 31,049 |
| Total assets | 55,498 | 44,003 | 45,249 | 41,622 | 41,282 |
| Employees (average) | 13 | 16 | 16 | 15 | 12 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | Not reportednote 1 | 21.6% | 3.1% | 16% | -17% |
| EBIT margin (overskudsgrad) | 2.5% | 4.6% | 5.3% | 3.8% | 6.3% |
| EBITDA | 1,308 | 2,968 | 3,533 | 2,857 | 3,905 |
| EBITDA margin | 2.6% | 4.8% | 5.5% | 3.9% | 6.3% |
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 | -20% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -15,424note 3 | -12,112note 3 | -18,232note 3 | -11,262note 3 | -22,697note 3 |
| Gearing, NIBD / EBITDA | Net cashnote 3 | Net cashnote 3 | Net cashnote 3 | Net cashnote 3 | Net cashnote 3 |
| ROIC (afkast af investeret kapital) | 5.8%note 3 | 18.2%note 3 | 20.1%note 3 | 15.1%note 3 | 23.7%note 3 |
| Capex (investeringer i anlægsaktiver) | 272note 4 | 73note 5 | 100note 5 | 0note 5 | Not reportednote 6 |
| Capex % of sales (investeringer i procent af omsætningen) | 0.5%note 4 | 0.1%note 5 | 0.2%note 5 | 0%note 5 | Not reportednote 6 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -2,854note 3 | -4,126note 3 | -16,284note 3 | -7,362note 3 | -20,483note 3 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 26 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 25 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 28 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 29 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 14 Jul 2022
Each registered value from the day it took effect, newest first.
Demerger (Spaltning), as the receiving company (Modtagende selskab)
From CVR, read 6 Nov 2026. Text such as the signing rule and purpose is shown as registered.
12 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Direktion:
Fratrådte:
Isabel Vandenberk, den 24.07.2025.
Tiltrådte:
Anne Bitzer, den 24.07.2025, Sofia Raquel Paulos Ferreira Alves da Silva, den 24.07.2025.
Direktion:
Fratrådte:
Gitte Schou Petersen, den 13.06.2025.
Tiltrådte:
Karl Johan Sundt, den 13.06.2025.
Ny adresse: Bredgade 6, 3., 1260 København K
Direktion:
Fratrådte:
Torstein Ljøkjel Erskov Winterstø, den 28.05.2021, Catherine Rebecca Sidgreaves, den 28.05.2021, Funda Zeynep Ekincioglu, den 28.05.2021.
Tiltrådte:
Torben Dahl, den 28.05.2021, Gitte Schou Petersen, den 28.05.2021.
Direktion:
Fratrådte:
Andreas Daugaard Jørgensen, den 01.02.2021.
Tiltrådte:
Catherine Rebecca Sidgreaves, den 01.02.2021.
Vedtægter ændret: 01.11.2020
Kapitalforhøjelsen er besluttet den 01.11.2020.
kr. 10,00, indbetalt ved spaltning, kurs 212.879.860,00.
Kapitalen udgør herefter kr. 40.010,00.
Kapitalforhøjelsen er sket i forbindelse med spaltning. Kapitalforhøjelsen blev ved en fejl ikke registreret ved spaltningen, registreret den 12.11.2020.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående spaltning. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en spaltningsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende virksomheder må antages at være tilstrækkeligt sikrede efter spaltningen.
Aktiver og gæld er overdraget fra CVR-nummer: 29883718 MSD DANMARK ApS.
Vedtægter ændret: 01.11.2020
Ny adresse: c/o MSD Danmark ApS, Havneholmen 25, 1561 København V
Vedtægter ændret: 06.05.2020
Nyt navn: Organon Denmark ApS
Ny adresse: Havneholmen 25, 1561 København V
Ny kommune: København
Stiftelsesdato: 24.02.2020.
Virkningsdato: 24.02.2020.
Seneste vedtægtsdato: 24.02.2020.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
MSD Human Health Holding BV, Kloosterstraat 6, , 5349 AB Oss, Holland, den 24.02.2020.
Direktion:
Andreas Daugaard Jørgensen, den 24.02.2020, Torstein Winterstø Ljøkjel, den 24.02.2020, Funda Zeynep Ekincioglu, den 24.02.2020.
Selskabet tegnes af en direktør alene eller af den samlede direktion..
Revision:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 24.02.2020.
Første regnskabsår:
24.02.2020 - 31.12.2020.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at udøve virksomhed indenfor industri og handel samt al virksomhed, som efter direktionens skøn har forbindelse hermed.
1 registered in CVR.
P-number 1025599175Bredgade 6, 1260 København K
No other current company drawn.
No other current company drawn.
No other current company drawn.
